Vitamin	O
E	O
inhibits	O
experimental	O
carcinogenesis	O
and	O
tumour	B-Cancer
angiogenesis	O
.	O

In	O
an	O
experiment	O
in	O
which	O
vitamin	O
E	O
inhibited	O
carcinogenesis	O
,	O
it	O
was	O
found	O
that	O
tumour	B-Cancer
angiogenesis	O
and	O
tumour	O
growth	O
-	O
factor	O
alpha	O
(	O
TGF	O
alpha	O
)	O
expression	O
were	O
also	O
inhibited	O
.	O

Forty	O
male	O
golden	O
hamsters	O
were	O
divided	O
into	O
four	O
equal	O
groups	O
.	O

Group	O
1	O
animals	O
had	O
the	O
left	B-Organism_subdivision
buccal	I-Organism_subdivision
pouches	I-Organism_subdivision
painted	O
three	O
times	O
weekly	O
with	O
7	O
,	O
12	O
-	O
dimethylbenz	O
(	O
a	O
)	O
anthracene	O
(	O
DMBA	O
)	O
for	O
14	O
weeks	O
.	O

Group	O
2	O
animals	O
had	O
the	O
same	O
procedure	O
of	O
DMBA	O
applications	O
but	O
also	O
received	O
alpha	O
tocopherol	O
.	O

Groups	O
3	O
and	O
4	O
were	O
vitamin	O
E	O
and	O
untreated	O
controls	O
.	O

Angiogenesis	O
was	O
studied	O
with	O
factor	O
8	O
-	O
related	O
antigen	O
(	O
F8	O
-	O
RA	O
)	O
which	O
identifies	O
endothelial	B-Cell
cells	I-Cell
.	O

TGF	O
alpha	O
was	O
studied	O
with	O
the	O
appropriate	O
antibody	O
.	O

Staining	O
was	O
effected	O
by	O
the	O
standard	O
avidin	O
-	O
biotin	O
horseradish	O
peroxidase	O
system	O
.	O

Mean	O
tumour	B-Cancer
volume	O
was	O
significantly	O
lower	O
in	O
the	O
DMBA	O
-	O
vitamin	O
E	O
group	O
compared	O
to	O
the	O
tumour	B-Cancer
control	O
group	O
.	O

Angiogenesis	O
was	O
significantly	O
inhibited	O
in	O
the	O
DMBA	O
-	O
vitamin	O
E	O
group	O
and	O
TGF	O
alpha	O
expression	O
was	O
also	O
inhibited	O
.	O

It	O
is	O
suggested	O
that	O
inhibition	O
of	O
tumour	B-Cancer
angiogenesis	O
by	O
vitamin	O
E	O
may	O
be	O
an	O
additional	O
mechanism	O
for	O
the	O
anticancer	B-Cancer
action	O
of	O
vitamin	O
E	O
.	O

